-+ 0.00%
-+ 0.00%
-+ 0.00%

HEALTH CANADA APPROVES LILLY'S MOUNJARO® (TIRZEPATIDE) TO REDUCE CARDIOVASCULAR RISK IN ADULTS WITH TYPE 2 DIABETES

Reuters·11/18/2026 18:00:08

Please log in to view news